Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas
Shalini Sundramurthi Chelliah, Ervin Ashley Lourdes Paul, Muhamad Noor Alfarizal Kamarudin, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1169-1169
Open Access | Times Cited: 20

Showing 20 citing articles:

Glioblastoma Treatment: State-of-the-Art and Future Perspectives
Alejandro Rodríguez-Camacho, José Guillermo Flores-Vázquez, Júlia Moscardini-Martelli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7207-7207
Open Access | Times Cited: 77
Recent advances in drug delivery systems for targeting brain tumors
Yi Zhao, Ping Yue, Yao Peng, et al.
Drug Delivery (2023) Vol. 30, Iss. 1, pp. 1-18
Open Access | Times Cited: 43
In Vitro Glioblastoma Model on a Plate for Localized Drug Release Study from a 3D-Printed Drug-Eluted Hydrogel Mesh
Behnad Chehri, Kaiwen Liu, Golnaz Vaseghi, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 363-363
Open Access | Times Cited: 5
Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-Chemotherapy
Weiguo Gu, Jiaming Tang, Penghui Liu, et al.
Therapeutics and Clinical Risk Management (2025) Vol. Volume 21, pp. 35-53
Open Access
Chemotactic nanomotor for multimodal combined therapy of glioblastoma
Ting Li, Lin Chen, Yunxin Xue, et al.
Science China Chemistry (2024) Vol. 67, Iss. 4, pp. 1277-1288
Closed Access | Times Cited: 4
The Phytochemical Potential for Brain Disease Therapy and the Possible Nanodelivery Solutions for Brain Access
Yang Liu, Zhouchun Chen, Aijie Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
Jing Zhou, Luohong Li, Minqi Jia, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 7207-7221
Open Access | Times Cited: 19
Radiotherapy of High-Grade Gliomas: First Half of 2021 Update with Special Reference to Radiosensitization Studies
Guido Fròsina
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8942-8942
Open Access | Times Cited: 16
Hydrolytic instability and low-loading levels of temozolomide to magnetic PLGA nanoparticles remain challenging against glioblastoma therapy
Fatih Şentürk, Soner Çakmak, Menemşe Gümüşderelioğlu, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 68, pp. 103101-103101
Closed Access | Times Cited: 11
FLOT1, stabilized by WTAP/IGF2BP2 mediated N6-methyladenosine modification, predicts poor prognosis and promotes growth and invasion in gliomas
Tao Song, Zhongxu Hu, Chong Zeng, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16280-e16280
Open Access | Times Cited: 6
ELTD1 Review: New Regulator of Angiogenesis in Glioma.
Iuliana Buzatu, Daniela Elise Tache, Elena Victoria Manea Carneluti, et al.
PubMed (2024) Vol. 49, Iss. 4, pp. 495-502
Closed Access | Times Cited: 1
Pathway‐based stratification of gliomas uncovers four subtypes with different TME characteristics and prognosis
Ruoyu Huang, Bo Han, Ying Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 1
Splicing dysregulation in glioblastoma alters the function of cell migration‐related genes
Minu Seong, Pedro Bak‐Gordon, Zhaoqi Liu, et al.
Glia (2024)
Open Access | Times Cited: 1
Combined carboplatin and etoposide chemotherapy for patients with recurrent glioma
Jianxin Chen, Yuze Zhao, Xinyu Hou, et al.
Annals of Palliative Medicine (2021) Vol. 10, Iss. 12, pp. 12650-12656
Open Access | Times Cited: 7
Monte Carlo-based optimization of glioma capsule design for enhanced brachytherapy
Dongjie Li, Yu Liang, Gang Yao, et al.
Applied Radiation and Isotopes (2023) Vol. 201, pp. 111014-111014
Closed Access | Times Cited: 2
Splicing dysregulation in glioblastoma alters the function of cell migration-related genes
Minu Seong, Pedro Bak‐Gordon, Zhaoqi Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Elevated Fras1-related extracellular matrix 3 in isocitrate dehydrogenase 1-mutant astrocytoma World Health Organization grade 4 predicts favorable prognosis in glioma: A bioinformatic and experimental analysis
Zuoxin Zhang, Guo‐Hao Huang, Tingting Wang, et al.
Glioma (2023) Vol. 6, Iss. 4, pp. 31-42
Open Access | Times Cited: 1
Gold nanoparticles associated with temozolomide for glioblastoma Multiforme Treatment
Vanessa Dias Gialluca, Vitor Gabriel Poli de Lima, Aloísio Caixeta, et al.
Research Society and Development (2021) Vol. 10, Iss. 11, pp. e146101119406-e146101119406
Open Access | Times Cited: 3
Recent Advances in the Treatment of Glioblastoma
·艾麦尔 艾山
Advances in Clinical Medicine (2023) Vol. 13, Iss. 04, pp. 6681-6685
Closed Access
Page 1

Scroll to top